Literature DB >> 23014947

Catalysts to withdrawal from familial ovarian cancer screening for surgery and reactions to discontinued screening: a qualitative study.

Kate J Lifford1, Alison Clements, Lindsay Fraser, Deborah Lancastle, Kate Brain.   

Abstract

Women at high risk of familial ovarian cancer face a potentially difficult risk management choice between unproven ovarian cancer screening (OCS) and bilateral salpingo-oophorectomy (BSO). It is not fully understood why women who initially opt for OCS may later undergo BSO, nor what the impact of this may be. This study explored the catalysts for surgery and reactions to discontinuing OCS. Semi-structured interviews were completed with 21 women who had undergone surgery having initially chosen OCS to explore their screening experiences, reasons for and feelings about surgery, and reactions to discontinuing OCS. The invasive nature and frequency of OCS were not by themselves a catalyst for surgery. A number of catalysts, including abnormal OCS test results, and secondary considerations, such as age-related factors, were found to prompt surgery. The emotional impact of discontinuing OCS following BSO varied between relief, acceptance, and loss of reassurance. OCS appears to be an acceptable risk management strategy under certain circumstances, but varying factors can prompt the decision to opt instead for BSO. The complexity of this management change decision should not be underestimated and needs to be taken into account by clinicians assisting women making choices. These findings highlight the importance of the timing of decision-making about BSO and that risk management options need routine reconsideration, through clinical discussions, information and support.

Entities:  

Mesh:

Year:  2013        PMID: 23014947     DOI: 10.1007/s10689-012-9567-x

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  21 in total

1.  A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy.

Authors:  N Hallowell
Journal:  Psychooncology       Date:  2000 Nov-Dec       Impact factor: 3.894

2.  Illness representations and distress in women undergoing screening for familial ovarian cancer.

Authors:  D Lancastle; K Brain; C Phelps
Journal:  Psychol Health       Date:  2011-07-07

3.  Deciding about prophylactic oophorectomy: what is important to women at increased risk of ovarian cancer?

Authors:  A Fry; R Rush; C Busby-Earle; A Cull
Journal:  Prev Med       Date:  2001-12       Impact factor: 4.018

4.  Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

Authors:  Amy Finch; Mario Beiner; Jan Lubinski; Henry T Lynch; Pal Moller; Barry Rosen; Joan Murphy; Parviz Ghadirian; Eitan Friedman; William D Foulkes; Charmaine Kim-Sing; Teresa Wagner; Nadine Tung; Fergus Couch; Dominique Stoppa-Lyonnet; Peter Ainsworth; Mary Daly; Babara Pasini; Ruth Gershoni-Baruch; Charis Eng; Olufunmilayo I Olopade; Jane McLennan; Beth Karlan; Jeffrey Weitzel; Ping Sun; Steven A Narod
Journal:  JAMA       Date:  2006-07-12       Impact factor: 56.272

5.  Anxiety/uncertainty reduction as a motivation for interest in prophylactic oophorectomy in women with a family history of ovarian cancer.

Authors:  K E Hurley; S M Miller; J W Costalas; D Gillespie; M B Daly
Journal:  J Womens Health Gend Based Med       Date:  2001-03

6.  Risk-reduction surgery decisions in high-risk women seen for genetic counseling.

Authors:  Jessica A Ray; Lois J Loescher; Molly Brewer
Journal:  J Genet Couns       Date:  2005-12       Impact factor: 2.537

7.  Withdrawal from familial ovarian cancer screening for surgery: findings from a psychological evaluation study (PsyFOCS).

Authors:  Kate J Lifford; Lindsay Fraser; Adam N Rosenthal; Mark T Rogers; Deborah Lancastle; Ceri Phelps; Eila K Watson; Alison Clements; Rachel Iredale; Ian Jacobs; Usha Menon; Kate E Brain
Journal:  Gynecol Oncol       Date:  2011-10-15       Impact factor: 5.482

8.  An exploratory qualitative study of women's perceptions of risk management options for familial ovarian cancer: implications for informed decision making.

Authors:  Kate Brain; Clare Gravell; Elizabeth France; Alison Fiander; Jonathon Gray
Journal:  Gynecol Oncol       Date:  2004-03       Impact factor: 5.482

9.  Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.

Authors:  A Fuchsia Howard; Joan L Bottorff; Lynda G Balneaves; Charmaine Kim-Sing
Journal:  BMC Womens Health       Date:  2010-08-05       Impact factor: 2.809

10.  Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers.

Authors:  Angela R Bradbury; Comfort N Ibe; James J Dignam; Shelly A Cummings; Marion Verp; Melody A White; Grazia Artioli; Laura Dudlicek; Olufunmilayo I Olopade
Journal:  Genet Med       Date:  2008-03       Impact factor: 8.822

View more
  3 in total

1.  Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female Lynch syndrome mutation carriers.

Authors:  Holly Etchegary; Elizabeth Dicks; Kathy Watkins; Sabrina Alani; Lesa Dawson
Journal:  Hered Cancer Clin Pract       Date:  2015-03-19       Impact factor: 2.857

Review 2.  Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision.

Authors:  Kelsey E Lewis; Karen H Lu; Amber M Klimczak; Samuel C Mok
Journal:  Cancers (Basel)       Date:  2018-02-21       Impact factor: 6.639

3.  Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine.

Authors:  Emily C Kight; Iftak Hussain; Audrey K Bowden; Frederick R Haselton
Journal:  Sci Rep       Date:  2021-11-09       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.